Drug factory · FDA FEI 3008822771
MSN Organics Private Limited
Sy. No. 224/A, Bibinagar (Village), Bibinagar(Mandal), Yadadri Bhuvanagiri District, India
Problems found, fixed voluntarily at FDA's last inspection, Mar 31, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2013: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Capecitabine | Makes the active ingredient | Cipla USA., Inc. | 69097-948, 69097-949 |
| Monomethyl | Makes the active ingredient and tests it | Cipla USA., Inc. | 69097-322, 69097-323, 69097-552 |
| Sildenafil | Makes the active ingredient | HEC Pharm USA Inc. | 72303-0845, 72303-0846, 72303-0847 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 31, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 11, 2016 | No problems found | Drug Quality Assurance | — |
| Aug 30, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.